Adipose Tissue Remodeling Beyond Weight Loss: New Insights Into Incretin-Based Therapies and Bariatric Surgery

Study limitation reported by the research below: “Bimagrumab (discussed in future directions) is investigational and not yet approved; phase 2 data only.”